SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549-1004
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): June 30, 2004
Ciphergen Biosystems, Inc.
(Exact name of Registrant as specified in its charter)
|
Delaware |
|
000-31617 |
|
33-059-5156 |
|
(State or other jurisdiction of |
|
[Commission File Number] |
|
(I.R.S. Employer |
|
incorporation or organization) |
|
|
|
Identification Number) |
6611 Dumbarton Circle
Fremont, CA 94555
(Address of principal executive offices)
(510) 505-2100
(Registrant’s telephone number, including area code)
Item 7. Financial Statements and Exhibits
(c) Exhibits.
99.1 Press Release, dated June 30, 2004.
Item 12. Results of Operations and Financial Condition
On June 30, 2004, Ciphergen Biosystems, Inc. issued a press release announcing financial results for its fiscal second quarter ended June 30, 2004. The press release is attached as Exhibit 99.1 to this Form 8-K.
The information in this Current Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
CIPHERGEN BIOSYSTEMS, INC. |
|
|
|
|
|
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
Date: June 30, 2004 |
|
|
|
|
By: |
/S/ WILLIAM RICH |
|
|
|
|
|
|
|
|
William E. Rich |
|
|
|
|
|
|
|
|
President and Chief Executive Officer |
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
99.1 |
|
Press Release issued by Ciphergen Biosystems, Inc. on June 30, 2004 |
4